Tigo Energy to Recognize Residential Installers with Loyalty Program at Intersolar Europe 2024
10.6.2024 16:00:00 EEST | Business Wire | Press release
Tigo Energy, Inc. (NASDAQ: TYGO), a leading provider of intelligent solar and energy software solutions, today announced it will unveil the new Tigo Installer Loyalty Program for residential PV installers in EMEA at Intersolar Europe 2024. As sustainable energy sources comprised 30% of all energy generated globally in 2023, with solar becoming an increasingly large contributor to that output, Tigo Energy is committed to supporting and invigorating the solar industry through initiatives like this loyalty program. Through exclusive benefits and solutions, the Tigo Installer Loyalty Program will recognize the dedication and professionalism of installers who choose Tigo solutions, further supporting their continued success and emphasizing the vitality of all members of the solar value chain to ensure the health of the solar industry.
Intersolar Europe 2024 attendees are invited to learn more about the training requirements and other qualifications for the Tigo Installer Loyalty Program by attending one of the scheduled program overview presentations. A comprehensive calendar of these introductory sessions is available on this page. Tigo will also offer the opportunity to enroll in the program at the event.
“We have worked with Tigo for years, and we are delighted to see this initiative come to installers here in the EMEA region,” said Michael Schmittinger, Managing Director at MMS Communication GmbH & Co. KG. “Our technicians and system designers have gained much from the Tigo Academy training resources, so I am happy to see this platform continue to be a focus in the loyalty program. We look forward to getting involved, learning, contributing, and continuing to build our solar business.”
“As the solar industry converges on Intersolar Europe in Munich, we are excited to welcome PV professionals into our new Installer Loyalty Program, introduce our latest MLPE products, and showcase the power of Tigo software to enhance system performance,” said Mirko Bindi, Senior VP Sales EMEA & MD Europe at Tigo Energy. “At Tigo, we are building the technology and service-oriented culture to empower all solar installers to embrace continuous improvement and a dedication to quality across the entire solar value chain. Underpinning these initiatives is a constantly evolving set of software capabilities that are quickly becoming the catalyst to achieving these goals, and we are very excited to showcase all of this at Intersolar Europe this year.”
With three tiers of participation, the Tigo Installer Loyalty Program offers progressively more valuable benefits for participants, including co-branding, homeowner sales leads, customized collateral, and promotion via the Tigo newsletter. Program participants will also be able to gain early access to new product developments, including participation in Tigo installer council sessions to provide the Company feedback. In addition to the new loyalty program, Tigo will showcase the Tigo EI Residential Solution, now extended to e-mobility with the GO EV Charger. The Company will also showcase the recently-released TS4-X, a new family of Flex MLPE solutions for high-power solar modules, providing safety, monitoring, optimization, and a new Multi-Factor Rapid Shutdown (MFRS) capability for energy-critical applications. Remaining true to the Company’s commitment to open architectures and broad compatibility, products within the TS4-X family work with the largest selection of third-party inverters, supporting the latest high-power and bifacial solar modules, up to 800W.
“We have carried Tigo products in our portfolio for more than ten years, and the new high-power TS4-X optimizers are an outstanding addition to our product range,” said Justin Gann, marketing manager for products and suppliers at Krannich Group GmbH. “We will exhibit the entire range of Tigo solutions at Intersolar this year because these products have proven to be very reliable and of high quality, and they are becoming increasingly popular with our customers. We are delighted to have a high-quality professional provider like Tigo in our portfolio.”
Additionally, Tigo will hold two Technical Coffee Breaks, during which solar professionals can review the specifications of the new TS4-X product family and the EI Residential Solution with members of the Tigo product team. Participation in the Technical Coffee Breaks is free, and the sessions will be held on June 19th and 20th at 16:00 at the Tigo booth (#B4.239).
Please visit the scheduling page here to view a complete list of partners displaying Tigo solutions, register for an Installer Loyalty Program presentation, or schedule a meeting with a member of the Tigo team. To inquire about the Installer Loyalty Program, visit here.
About Tigo Energy
Founded in 2007, Tigo is a worldwide leader in the development and manufacture of smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Tigo combines its Flex MLPE (Module Level Power Electronics) and solar optimizer technology with intelligent, cloud-based software capabilities for advanced energy monitoring and control. Tigo MLPE products maximize performance, enable real-time energy monitoring, and provide code-required rapid shutdown at the module level. The company also develops and manufactures products such as inverters and battery storage systems for the residential solar-plus-storage market. For more information, please visit www.tigoenergy.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240610982934/en/
Contact information
Technica Communications
Cait Caviness
Email: tigoenergy@technica.inc
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 16:13:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of disease progression or death compared with standard chemoimmunotherapy. Full results from the MANGROVE study will be presented during the Plenary Scientific Session at the 68th American Society of Hematology (ASH) Annual Meeting on December 13, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103605806/en/ BeOne Medicines' flagship U.S. manufacturing and clinical R&D facility at the P
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 16:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstracts at the 2026 American Society of Hematology (ASH) Annual Meeting, to beheld December 12 – 15, 2026, in New Orleans. “Our ASH presentations demonstrate meaningful progress across our Hematology portfolio to advance novel treatment approaches for people with serious hematologic conditions,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "We are particularly encouraged by the continued clinical progress of INCA033989 in myelofibrosis (MF) and essential thrombocythemia (ET) and the data for latarcibart in von Willebrand disease (VWD) - data that support our goal of advancing differentiated medicines with the potential to meaningfully improve outcomes for patients." Details on key data presentations at ASH include: Oral Presentations INCA033989 (mutCALR) In JAK-Inhibitor Naive Patients with Myelof
Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 16:00:00 EET | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMware and IBM environments, without having to go through a lengthy individual tender process. Through Rimini Support™, organizations gain access to a support alternative enabling them to significantly reduce their historical support costs, improve service quality and support respons
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 16:00:00 EET | Press release
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e
Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 15:41:00 EET | Press release
Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
